Alternatives to AIDGenomics

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered spatial biology platform for precision medicine and drug development.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

A medical platform connecting patients and physicians with genetic expertise.

Transforming healthcare by turning scientific fiction into scientific facts.

A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing AI-driven solutions for optimizing chronic condition treatment efficacy and tolerance.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Leveraging the adaptive immune system to diagnose and treat disease.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

Developing AI-driven technology for mental health treatments, focusing on PTSD.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

Sensifai desarrolla reconocimiento potenciado por IA, soluciones DeFi seguras y plataformas Web3 innovadoras.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Microbiome technology platform for developing novel therapeutics.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Medical device company developing advanced sensor technology for oncology treatment.

AI-powered platform enhancing surgical precision and patient outcomes through data-driven recommendations.

Developing advanced bio-integrated devices for enhanced medical diagnostics and therapeutics.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Personalized medical testing tool to optimize drug therapy for depression.

Biomedical platform with intelligent search for medical citations and clinical trial recruitment.

AI-powered platform for personalized cell therapy development and manufacturing.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Data-driven software solutions for precision medicine and pharmaceutical development.

AI-powered breast cancer detection and risk assessment solutions.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

AI-powered epiproteomic analysis platform for mass spectrometry data.